OBJECTIVE: In adults, hypothalamic gliosis has been documented using quantitative T2 neuroimaging, whereas functional magnetic resonance imaging (fMRI) has shown a defective hypothalamic response to nutrients. No studies have yet evaluated these hypothalamic abnormalities in children with obesity. METHODS: Children with obesity and lean controls underwent quantitative MRI measuring T2 relaxation time, along with continuous hypothalamic fMRI acquisition to evaluate early response to glucose ingestion. RESULTS: Children with obesity (N = 11) had longer T2 relaxation times, consistent with gliosis, in the mediobasal hypothalamus (MBH) compared to controls (N = 9; P = 0.004). Moreover, there was a highly significant group*region interaction (P = 0.002), demonstrating that signs of gliosis were specific to MBH and not to reference regions. Longer T2 relaxation times correlated with measures of higher adiposity, including visceral fat percentage (P = 0.01). Mean glucose-induced hypothalamic blood oxygen-level dependent signal change did not differ between groups (P = 0.11). However, mean left MBH T2 relaxation time negatively correlated with glucose-induced hypothalamic signal change (P < 0.05). CONCLUSION: Imaging signs of hypothalamic gliosis were present in children with obesity and positively associated with more severe adiposity. Children with the strongest evidence for gliosis showed the least activation after glucose ingestion. These initial findings suggest that the hypothalamus is both structurally and functionally affected in childhood obesity.
OBJECTIVE: In adults, hypothalamic gliosis has been documented using quantitative T2 neuroimaging, whereas functional magnetic resonance imaging (fMRI) has shown a defective hypothalamic response to nutrients. No studies have yet evaluated these hypothalamic abnormalities in children with obesity. METHODS:Children with obesity and lean controls underwent quantitative MRI measuring T2 relaxation time, along with continuous hypothalamic fMRI acquisition to evaluate early response to glucose ingestion. RESULTS:Children with obesity (N = 11) had longer T2 relaxation times, consistent with gliosis, in the mediobasal hypothalamus (MBH) compared to controls (N = 9; P = 0.004). Moreover, there was a highly significant group*region interaction (P = 0.002), demonstrating that signs of gliosis were specific to MBH and not to reference regions. Longer T2 relaxation times correlated with measures of higher adiposity, including visceral fat percentage (P = 0.01). Mean glucose-induced hypothalamic blood oxygen-level dependent signal change did not differ between groups (P = 0.11). However, mean left MBH T2 relaxation time negatively correlated with glucose-induced hypothalamic signal change (P < 0.05). CONCLUSION: Imaging signs of hypothalamic gliosis were present in children with obesity and positively associated with more severe adiposity. Children with the strongest evidence for gliosis showed the least activation after glucose ingestion. These initial findings suggest that the hypothalamus is both structurally and functionally affected in childhood obesity.
Authors: Khader M Hasan; Indika S Walimuni; Humaira Abid; Richard E Frye; Linda Ewing-Cobbs; Jerry S Wolinsky; Ponnada A Narayana Journal: J Neurosci Date: 2011-11-16 Impact factor: 6.167
Authors: William A Banks; Alan B Coon; Sandra M Robinson; Asif Moinuddin; Jessica M Shultz; Ryota Nakaoke; John E Morley Journal: Diabetes Date: 2004-05 Impact factor: 9.461
Authors: Kelly A Posey; Deborah J Clegg; Richard L Printz; Jaeman Byun; Gregory J Morton; Anuradha Vivekanandan-Giri; Subramaniam Pennathur; Denis G Baskin; Jay W Heinecke; Stephen C Woods; Michael W Schwartz; Kevin D Niswender Journal: Am J Physiol Endocrinol Metab Date: 2008-12-30 Impact factor: 4.310
Authors: Caroline Baufeld; Anja Osterloh; Stefan Prokop; Kelly R Miller; Frank L Heppner Journal: Acta Neuropathol Date: 2016-07-08 Impact factor: 17.088
Authors: Juliana C Moraes; Andressa Coope; Joseane Morari; Dennys E Cintra; Erika A Roman; José R Pauli; Talita Romanatto; José B Carvalheira; Alexandre L R Oliveira; Mario J Saad; Licio A Velloso Journal: PLoS One Date: 2009-04-02 Impact factor: 3.240
Authors: Zoe Mestre; Amanda Bischoff-Grethe; Christina E Wierenga; Terry Jernigan; Dawn M Eichen; Linda Chang; Thomas Ernst; Kerri N Boutelle Journal: Obesity (Silver Spring) Date: 2020-06-05 Impact factor: 5.002
Authors: Jennifer L Rosenbaum; Susan J Melhorn; Stefan Schoen; Mary F Webb; Mary Rosalynn B De Leon; Madelaine Humphreys; Kristina M Utzschneider; Ellen A Schur Journal: Diabetes Care Date: 2022-02-01 Impact factor: 19.112
Authors: Shan Luo; Brendan C Angelo; Ting Chow; John R Monterosso; Paul M Thompson; Anny H Xiang; Kathleen A Page Journal: Diabetes Care Date: 2021-04-07 Impact factor: 19.112
Authors: Leticia E Sewaybricker; Susan J Melhorn; Mary K Askren; Mary F Webb; Vidhi Tyagi; Mary Rosalynn B De Leon; Thomas J Grabowski; William W Seeley; Ellen A Schur Journal: Int J Obes (Lond) Date: 2019-04-09 Impact factor: 5.095
Authors: Josephine L Robb; Nicole A Morrissey; Paul G Weightman Potter; Hannah E Smithers; Craig Beall; Kate L J Ellacott Journal: Neuroscience Date: 2019-11-22 Impact factor: 3.590
Authors: Leticia E Sewaybricker; Susan J Melhorn; Afroditi Papantoni; Mary F Webb; Jun Hua; Christian L Roth; Susan Carnell; Ellen A Schur Journal: Pediatr Obes Date: 2020-10-20 Impact factor: 4.000